Erlend Skaga

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Newly Diagnosed

End Stage Renal Disease

Top Venues

Journal of cancer research and clinical oncology

Neuro-oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Marit Brynjulvsen, Elise Solli, Maria Walewska, Manuela Zucknick, Luna Djirackor, Iver A Langmoen, Awais Ahmad Mughal, Erlend Skaga, Einar O Vik-Mo, Cecilie J Sandberg
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling. Cancers 15 (24) (2023)
Marit Brynjulvsen, Elise Solli, Maria Walewska, Manuela Zucknick, Luna Djirackor, Iver A Langmoen, Awais Ahmad Mughal, Erlend Skaga, Einar O Vik-Mo, Cecilie J Sandberg
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling. Cancers 15 (24) (2023)
Eduardo Erasmo Mendoza Mireles, Erlend Skaga, Andres Server Alonso, Henning Leske, Petter Brandal, Eirik Helseth, Pål A Rønning, Einar Osland Vik-Mo
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study. Neuro-oncology practice 10 (6) (2023)
Erlend Skaga, Marthe Andrea Skretteberg, Tom Børge Johannesen, Petter Brandal, Einar O Vik-Mo, Eirik Helseth, Iver A Langmoen
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply? Neuro-oncology advances 3 (1) (2021)
Kirsten Strømme Kierulf-Vieira, Cecilie Jonsgar Sandberg, Jo Waaler, Kaja Lund, Erlend Skaga, Birthe Mikkelsen Saberniak, Ioannis Panagopoulos, Petter Brandal, Stefan Krauss, Iver Arne Langmoen, Einar Osland Vik-Mo
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation. Cancers 12 (6) (2020)
Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, Cecilie J Sandberg, Swapnil Potdar, Iver A Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O Vik-Mo
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment. Clinical and translational medicine 8 (1) (2019)
Erlend Skaga, Ida Ø Skaga, Zanina Grieg, Cecilie J Sandberg, Iver A Langmoen, Einar O Vik-Mo
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy. Journal of cancer research and clinical oncology 145 (6) (2019)
Erlend Skaga, Evgeny Kulesskiy, Artem Fayzullin, Cecilie J Sandberg, Swapnil Potdar, Aija Kyttälä, Iver A Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O Vik-Mo
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma. BMC cancer 19 (1) (2019)